NeuroSense Therapeutics Ltd. (NRSN)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | — |
|
| Document and Entity Information | — |
|
| Audit Information | — |
|
| Statements | ||
| Consolidated Statements of Financial Position | — |
|
| Consolidated Statements of Financial Position (P) | — |
|
| Consolidated Statements of Income and Comprehensive Loss (P) | — |
|
| Consolidated Statements of Changes In Equity | — |
|
| Consolidated Statements of Income and Comprehensive Loss | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Changes In Equity (deficit) | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Notes | ||
| Basis of Preparation | — |
|
| Cash and Cash Equivalents | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Financial Instruments | — |
|
| Financing Income (expenses), Net | — |
|
| Financing Income, Net | — |
|
| General | — |
|
| General and Administrative Expenses | — |
|
| Income Taxes | — |
|
| Insider Trading Policies and Procedures | — |
|
| Lease | — |
|
| Liability In Respect of Warrants | — |
|
| Loss Per Share | — |
|
| Material Accounting Policies | — |
|
| Operating Lease | — |
|
| Other Current Liabilities | — |
|
| Other Payables | — |
|
| Other Receivables | — |
|
| Pay Vs Performance Disclosure | — |
|
| Property and Equipment, Net | — |
|
| Property, Plant and Equipment, Net | — |
|
| Related Parties Balances and Transactions | — |
|
| Research and Development Expenses | — |
|
| Segment Reporting | — |
|
| Share Based Payment | — |
|
| Shareholders' Equity | — |
|
| Significant Accounting Policy | — |
|
| Subsequent Events | — |
|